Science 15 June 1990: Vol. 248. no. 4961, pp. 1408 - 1410 DOI: 10.1126/science.1694043

Prev | Table of Contents | Next

Articles

Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities.

W. G. Stetler-Stevenson (2008)
Science Signaling 1, re6
 |  Abstract »  |  Full Text »  |  PDF »

Urinary Biomarkers Predict Brain Tumor Presence and Response to Therapy.

E. R. Smith, D. Zurakowski, A. Saad, R. M. Scott, and M. A. Moses (2008)
Clin. Cancer Res. 14, 2378-2386
 |  Abstract »  |  Full Text »  |  PDF »

Understanding Abnormalities in Vascular Specification and Remodeling.

J. M. Enciso and K. K. Hirschi (2005)
Pediatrics 116, 228-230
 |  Full Text »  |  PDF »

Osteoarthritis, angiogenesis and inflammation.

C. S. Bonnet and D. A. Walsh (2005)
Rheumatology 44, 7-16
 |  Abstract »  |  Full Text »  |  PDF »

ADAM 12 Cleaves Extracellular Matrix Proteins and Correlates with Cancer Status and Stage.

R. Roy, U. M. Wewer, D. Zurakowski, S. E. Pories, and M. A. Moses (2004)
J. Biol. Chem. 279, 51323-51330
 |  Abstract »  |  Full Text »  |  PDF »

Gabexate Mesilate Inhibits Colon Cancer Growth, Invasion, and Metastasis by Reducing Matrix Metalloproteinases and Angiogenesis.

W.-H. Yoon, Y.-J. Jung, T.-D. Kim, G. Li, B.-J. Park, J.-Y. Kim, Y.-C. Lee, J.-M. Kim, J.-I. Park, H.-D. Park, et al. (2004)
Clin. Cancer Res. 10, 4517-4526
 |  Abstract »  |  Full Text »  |  PDF »

Lumbar Disk Herniation: Correlation of Histologic Findings with Marrow Signal Intensity Changes in Vertebral Endplates at MR Imaging.

G. Schmid, A. Witteler, R. Willburger, C. Kuhnen, M. Jergas, and O. Koester (2004)
Radiology 231, 352-358
 |  Abstract »  |  Full Text »  |  PDF »

Angiogenesis as a target in rheumatoid arthritis.

A E Koch (2003)
Ann Rheum Dis 62, ii60-67
 |  Full Text »  |  PDF »

Structural and Functional Uncoupling of the Enzymatic and Angiogenic Inhibitory Activities of Tissue Inhibitor of Metalloproteinase-2 (TIMP-2): LOOP 6 IS A NOVEL ANGIOGENESIS INHIBITOR.

C. A. Fernandez, C. Butterfield, G. Jackson, and M. A. Moses (2003)
J. Biol. Chem. 278, 40989-40995
 |  Abstract »  |  Full Text »  |  PDF »

A Peptide with Three Hyaluronan Binding Motifs Inhibits Tumor Growth and Induces Apoptosis.

X.-M. Xu, Y. Chen, J. Chen, S. Yang, F. Gao, C. B. Underhill, K. Creswell, and L. Zhang (2003)
Cancer Res. 63, 5685-5690
 |  Abstract »  |  Full Text »  |  PDF »

Vascular Endothelial Growth Factor Isoforms and Their Receptors Are Expressed in Human Osteoarthritic Cartilage.

H. Enomoto, I. Inoki, K. Komiya, T. Shiomi, E. Ikeda, K.-i. Obata, H. Matsumoto, Y. Toyama, and Y. Okada (2003)
Am. J. Pathol. 162, 171-181
 |  Abstract »  |  Full Text »  |  PDF »

Advising Patients Who Seek Complementary and Alternative Medical Therapies for Cancer.

W. A. Weiger, M. Smith, H. Boon, M. A. Richardson, T. J. Kaptchuk, and D. M. Eisenberg (2002)
Ann Intern Med 137, 889-903
 |  Abstract »  |  Full Text »  |  PDF »

Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation.

G. F. Weber, S. Zawaideh, S. Hikita, V. A. Kumar, H. Cantor, and S. Ashkar (2002)
J. Leukoc. Biol. 72, 752-761
 |  Abstract »  |  Full Text »  |  PDF »

The Antiangiogenic Agent Neovastat (Ae-941) Induces Endothelial Cell Apoptosis.

D. Boivin, S. Gendron, E. Beaulieu, D. Gingras, and R. Beliveau (2002)
Mol. Cancer Ther. 1, 795-802
 |  Abstract »  |  Full Text »  |  PDF »

Dynamic In Vivo Changes in Tissue Inhibitors of Metalloproteinases 1 and 2, and Matrix Metalloproteinases 2 and 9, During Prostaglandin F2{alpha}-Induced Luteolysis in Sheep.

T. A. Towle, P. C.W. Tsang, R. A. Milvae, M. K. Newbury, and J. A. McCracken (2002)
Biol Reprod 66, 1515-1521
 |  Abstract »  |  Full Text »

The Antiangiogenic Agent Neovastat (Ae-941) Inhibits Vascular Endothelial Growth Factor-mediated Biological Effects.

R. Beliveau, D. Gingras, E. A. Kruger, S. Lamy, P. Sirois, B. Simard, M. G. Sirois, L. Tranqui, F. Baffert, E. Beaulieu, et al. (2002)
Clin. Cancer Res. 8, 1242-1250
 |  Abstract »  |  Full Text »  |  PDF »

Metalloproteinase Inhibition and the Response to Angioplasty and Stenting in Atherosclerotic Primates.

G. S. Cherr, S. J. Motew, J. A. Travis, J. Fingerle, L. Fisher, M. Brandl, J. K. Williams, and R. L. Geary (2002)
Arterioscler Thromb Vasc Biol 22, 161-166
 |  Abstract »  |  Full Text »  |  PDF »

Treatment of Kaposi Sarcoma With Oral Administration of Shark Cartilage in a Human Herpesvirus 8-Seropositive, Human Immunodeficiency Virus-Seronegative Homosexual Man.

J. D. Hillman, A. T. Peng, A. C. Gilliam, and S. C. Remick (2001)
Arch Dermatol 137, 1149-1152
 |  Full Text »  |  PDF »

HIF-1{alpha}-mediated Up-Regulation of Vascular Endothelial Growth Factor, Independent of Basic Fibroblast Growth Factor, Is Important in the Switch to the Angiogenic Phenotype during Early Tumorigenesis.

J. Fang, L. Yan, Y. Shing, and M. A. Moses (2001)
Cancer Res. 61, 5731-5735
 |  Abstract »  |  Full Text »  |  PDF »

Expression of Prolactin Gene and Secretion of Prolactin by Rat Retinal Capillary Endothelial Cells.

A. Ochoa, P. Montes de Oca, J. C. Rivera, Z. Dueñas, G. Nava, G. M. de la Escalera, and C. Clapp (2001)
Invest. Ophthalmol. Vis. Sci. 42, 1639-1645
 |  Abstract »  |  Full Text »

Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen.

M. Seandel, K. Noack-Kunnmann, D. Zhu, R. T. Aimes, and J. P. Quigley (2001)
Blood 97, 2323-2332
 |  Abstract »  |  Full Text »  |  PDF »

A Case of Tumor Betrayal : Biphasic Effects of TIMP-1 on Burkitt's Lymphoma.

L. Yan and M. A. Moses (2001)
Am. J. Pathol. 158, 1185-1190
 |  Full Text »  |  PDF »

Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.

G. Davis, K. Pintar Allen, R Salazar, and S. Maxwell (2001)
J. Cell Sci. 114, 917-930
 |  Abstract »  |  PDF »

Angioresistance of Thermally Modified Cartilage Grafts in the Chick Chorioallantoic Membrane Model.

B. J. F. Wong, A. M. Karamzadeh, M. J. Hammer-Wilson, L.-H. L. Liaw, J. S. Nelson, and T. E. Milner (2001)
Arch Facial Plast Surg 3, 24-27
 |  Abstract »  |  Full Text »  |  PDF »

The role of angiogenesis in rheumatoid arthritis: recent developments.

A. E. Koch (2000)
Ann Rheum Dis 59, i65-71
 |  Full Text »  |  PDF »

Thrombospondin-1 Is Downregulated by Anoxia and Suppresses Tumorigenicity of Human Glioblastoma Cells.

M. Tenan, G. Fulci, M. Albertoni, A.-C. Diserens, M.-F. Hamou, M. El Atifi-Borel, J.-J. Feige, M. S. Pepper, and E. G. Van Meir (2000)
J. Exp. Med. 191, 1789-1798
 |  Abstract »  |  Full Text »  |  PDF »

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.

J. Fang, Y. Shing, D. Wiederschain, L. Yan, C. Butterfield, G. Jackson, J. Harper, G. Tamvakopoulos, and M. A. Moses (2000)
PNAS 97, 3884-3889
 |  Abstract »  |  Full Text »  |  PDF »

Membrane Type 1 Matrix Metalloproteinase-associated Degradation of Tissue Inhibitor of Metalloproteinase 2 in Human Tumor Cell Lines.

E. Maquoi, F. Frankenne, E. Baramova, C. Munaut, N. E. Sounni, A. Remacle, A. Noel, G. Murphy, and J.-M. Foidart (2000)
J. Biol. Chem. 275, 11368-11378
 |  Abstract »  |  Full Text »  |  PDF »

Antiangiogenic Scheduling of Chemotherapy Improves Efficacy against Experimental Drug-resistant Cancer.

T. Browder, C. E. Butterfield, B. M. Kräling, B. Shi, B. Marshall, M. S. O’Reilly, and J. Folkman (2000)
Cancer Res. 60, 1878-1886
 |  Abstract »  |  Full Text »

Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells.

L Yan, M. Moses, S Huang, and D. Ingber (2000)
J. Cell Sci. 113, 3979-3987
 |  Abstract »  |  PDF »

Interaction with Endothelial Cells Is a Prerequisite for Branching Ductal-Alveolar Morphogenesis and Hyperplasia of Preneoplastic Human Breast Epithelial Cells: Regulation by Estrogen.

M. P. V. Shekhar, J. Werdell, and L. Tait (2000)
Cancer Res. 60, 439-449
 |  Abstract »  |  Full Text »

Regulation of Angiostatin Production by Matrix Metalloproteinase-2 in a Model of Concomitant Resistance.

M. S. O'Reilly, D. Wiederschain, W. G. Stetler-Stevenson, J. Folkman, and M. A. Moses (1999)
J. Biol. Chem. 274, 29568-29571
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Rat Corneal Angiogenesis by 16-kDa Prolactin and by Endogenous Prolactin-like Molecules.

Z. Duenas, L. Torner, A. M. Corbacho, A. Ochoa, G. Gutierrez-Ospina, F. Lopez-Barrera, F. A. Barrios, P. Berger, Gonzalo Martinez de la Escalera, and C. Carmen (1999)
Invest. Ophthalmol. Vis. Sci. 40, 2498-2505
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Bladder Carcinoma Angiogenesis, Stromal Support, and Tumor Growth by Halofuginone.

M. Elkin, I. Ariel, H.-Q. Miao, A. Nagler, M. Pines, N. de-Groot, A. Hochberg, and I. Vlodavsky (1999)
Cancer Res. 59, 4111-4118
 |  Abstract »  |  Full Text »  |  PDF »

The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro.

B. Kraling, D. Wiederschain, T Boehm, M Rehn, J. Mulliken, and M. Moses (1999)
J. Cell Sci. 112, 1599-1609
 |  Abstract »  |  PDF »

Autogenous Tissue-Engineered Cartilage: Evaluation as an Implant Material.

J. C. Britt and S. S. Park (1998)
Arch Otolaryngol Head Neck Surg 124, 671-677
 |  Abstract »  |  Full Text »  |  PDF »

Human TIMP-3 Is Expressed During Fetal Development, Hair Growth Cycle, and Cancer Progression.

K. Airola, M. Ahonen, N. Johansson, P. Heikkilä, J. Kere, V.-M. Kähäri, and U. K. Saarialho–Kere (1998)
J. Histochem. Cytochem. 46, 437-448
 |  Abstract »  |  Full Text »

Identification of Chondromodulin I as a Novel Endothelial Cell Growth Inhibitor. PURIFICATION AND ITS LOCALIZATION IN THE AVASCULAR ZONE OF EPIPHYSEAL CARTILAGE.

Y. Hiraki, H. Inoue, K.-i. Iyama, A. Kamizono, M. Ochiai, C. Shukunami, S. Iijima, F. Suzuki, and J. Kondo (1997)
J. Biol. Chem. 272, 32419-32426
 |  Abstract »  |  Full Text »  |  PDF »

Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha.

P. M. Yao, B. Maitre, C. Delacourt, J. M. Buhler, A. Harf, and C. Lafuma (1997)
Am J Physiol Lung Cell Mol Physiol 273, L866-L874
 |  Abstract »  |  Full Text »  |  PDF »

Manipulating Angiogenesis: From Basic Science to the Bedside.

M. S. Pepper (1997)
Arterioscler Thromb Vasc Biol 17, 605-619
 |  Abstract »  |  Full Text »

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways.

J. L. Arbiser, M. A. Moses, C. A. Fernandez, N. Ghiso, Y. Cao, N. Klauber, D. Frank, M. Brownlee, E. Flynn, S. Parangi, et al. (1997)
PNAS 94, 861-866
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of Endothelial Cell Growth by Macrophage-like U-937 Cell-derived Oncostatin M, Leukemia Inhibitory Factor, and Transforming Growth Factor beta 1.

S. Takashima and M. Klagsbrun (1996)
J. Biol. Chem. 271, 24901-24906
 |  Abstract »  |  Full Text »  |  PDF »

Replacing a Surface Loop Endows Ribonuclease A with Angiogenic Activity.

R. T. Raines, M. P. Toscano, D. M. Nierengarten, J. H. Ha, and R. Auerbach (1995)
J. Biol. Chem. 270, 17180-17184
 |  Abstract »  |  Full Text »  |  PDF »

Estrogen Promotes Angiogenic Activity in Human Umbilical Vein Endothelial Cells In Vitro and in a Murine Model.

D. E. Morales, K. A. McGowan, D. S. Grant, S. Maheshwari, D. Bhartiya, M. C. Cid, H. K. Kleinman, and H. W. Schnaper (1995)
Circulation 91, 755-763
 |  Abstract »  |  Full Text »

Systemic Antiangiogenic Therapy for Choroidal Neovascularization: What Is the Role of Interferon Alfa?.

D. R. Guyer, A. P. Adamis, E. S. Gragoudas, J. Folkman, J. S. Slakter, and L. A. Yannuzzi (1992)
Arch Ophthalmol 110, 1383-1384
 |  Abstract »  |  PDF »

Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex.

S Nakamura, S Sakurada, S. Salahuddin, Y Osada, N. Tanaka, N Sakamoto, M Sekiguchi, and R. Gallo (1992)
Science 255, 1437-1440
 |  Abstract »  |  PDF »

A PROTEIN FROM CARTILAGE INHIBITS ANGIOGENESIS.

(1990)
Journal Watch (General) 1990, 3
 |  Full Text »

To Advertise   |   Find Products